Texas Instruments Stock in Focus

Large-cap Technology company Texas Instruments has logged a 1.4% change today on a trading volume of 6,176,423. The average volume for the stock is 5,043,552.

Texas Instruments Incorporated designs, manufactures, and sells semiconductors to electronics designers and manufacturers in the United States and internationally. Based in Dallas, United States the company has 33,000 full time employees and a market cap of $142,969,470,976. Texas Instruments currently offers its equity investors a dividend that yields 3.2% per year.

The company is now trading -3.45% away from its average analyst target price of $163.05 per share. The 26 analysts following the stock have set target prices ranging from $120.0 to $210.0, and on average give Texas Instruments a rating of hold.

Over the last 12 months TXN shares have declined by -11.0%, which represents a difference of -26.0% when compared to the S&P 500. The stock's 52 week high is $188.12 per share and its 52 week low is $139.48. Based on Texas Instruments's average net margin growth of 1.9% over the last 6 years, its core business remains strong and the stock price may recover in the long term.

Date Reported Total Revenue ($ k) Net Profit ($ k) Net Margins (%) YoY Growth (%)
2023 18,112,000 7,101,000 39 -11.36
2022 20,028,000 8,749,000 44 4.76
2021 18,344,000 7,769,000 42 7.69
2020 14,461,000 5,595,000 39 11.43
2019 14,383,000 5,017,000 35 0.0
2018 15,784,000 5,580,000 35
The above analysis is intended for educational purposes only and was performed on the basis of publicly available data. It is not to be construed as a recommendation to buy or sell any security. Any buy, sell, or other recommendations mentioned in the article are direct quotations of consensus recommendations from the analysts covering the stock, and do not represent the opinions of Market Inference or its writers. Past performance, accounting data, and inferences about market position and corporate valuation are not reliable indicators of future price movements. Market Inference does not provide financial advice. Investors should conduct their own review and analysis of any company of interest before making an investment decision.